Construction of an Excellent 7 mRNAsi-Related Gene Model Based on Cancer Stem Cells for Predicting Survival Outcome of Cervical Cancer

Figure 9

Correlation between RiskScore and clinical features and dryness. (a) RiskScore differences between different clinicopathological subgroups. (b) RiskScore differences between different mRNAsi subgroups and molecular subtypes. (c) Association between the mRNAsi subgroups, the molecular subtypes, and the RiskScore subgroups. (d) Survival analysis of the high- and low-risk groups in the clinicopathological subgroups.

(a)

(b)

(c)

(d)